These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24909887)

  • 21. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
    Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
    J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity.
    Sumaria N; van Dommelen SL; Andoniou CE; Smyth MJ; Scalzo AA; Degli-Esposti MA
    Immunol Cell Biol; 2009 Oct; 87(7):559-66. PubMed ID: 19564888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential requirement of perforin and IFN-gamma in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen.
    Prévost-Blondel A; Neuenhahn M; Rawiel M; Pircher H
    Eur J Immunol; 2000 Sep; 30(9):2507-15. PubMed ID: 11009083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Variable Genomic NK Cell Receptor Locus Is a Key Determinant of CD4+ T Cell Responses During Viral Infection.
    Raynor J; Lin A; Hummel SA; Lampe K; Jordan M; Hoebe K; Hildeman DA
    Front Immunol; 2020; 11():197. PubMed ID: 32153566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
    Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
    J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS; Biron CA
    J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice.
    Li W; Hofer MJ; Noçon AL; Manders P; Campbell IL
    Virology; 2013 May; 439(2):152-62. PubMed ID: 23490048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perforin-deficient CD8+ T cells mediate fatal lymphocytic choriomeningitis despite impaired cytokine production.
    Storm P; Bartholdy C; Sørensen MR; Christensen JP; Thomsen AR
    J Virol; 2006 Feb; 80(3):1222-30. PubMed ID: 16414999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
    Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
    Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
    Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
    J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production.
    Nguyen KB; Biron CA
    J Immunol; 1999 May; 162(9):5238-46. PubMed ID: 10227998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin.
    Blaser C; Kaufmann M; Pircher H
    J Immunol; 1998 Dec; 161(12):6451-4. PubMed ID: 9862665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cells act as rheostats modulating antiviral T cells.
    Waggoner SN; Cornberg M; Selin LK; Welsh RM
    Nature; 2011 Nov; 481(7381):394-8. PubMed ID: 22101430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta.
    Sandberg K; Kemper P; Stalder A; Zhang J; Hobbs MV; Whitton JL; Campbell IL
    J Immunol; 1994 Jul; 153(1):220-31. PubMed ID: 8207238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.
    Madera S; Rapp M; Firth MA; Beilke JN; Lanier LL; Sun JC
    J Exp Med; 2016 Feb; 213(2):225-33. PubMed ID: 26755706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus.
    Nath PR; Gangaplara A; Pal-Nath D; Mandal A; Maric D; Sipes JM; Cam M; Shevach EM; Roberts DD
    Front Immunol; 2018; 9():2985. PubMed ID: 30643501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I interferon signaling in fibroblastic reticular cells prevents exhaustive activation of antiviral CD8
    Perez-Shibayama C; Islander U; Lütge M; Cheng HW; Onder L; Ring SS; De Martin A; Novkovic M; Colston J; Gil-Cruz C; Ludewig B
    Sci Immunol; 2020 Sep; 5(51):. PubMed ID: 32917792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription Factor IRF4 Promotes CD8
    Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
    Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.